{"id":7517,"date":"2019-01-29T00:00:00","date_gmt":"2019-01-28T23:00:00","guid":{"rendered":"https:\/\/idibell.cat\/blog\/2019\/01\/29\/salvem-vides-accelerar-la-recerca-per-curar-el-cancer\/"},"modified":"2020-07-28T09:46:40","modified_gmt":"2020-07-28T07:46:40","slug":"salvem-vides-accelerar-la-recerca-per-curar-el-cancer","status":"publish","type":"post","link":"https:\/\/idibell.cat\/2019\/01\/salvem-vides-accelerar-la-recerca-per-curar-el-cancer\/","title":{"rendered":"Salvem vides: Accelerar la recerca per curar el c\u00e0ncer"},"content":{"rendered":"

L\u2019IDIBELL acaba d\u2019engegar la seva campanya anual de recaptaci\u00f3 de fons, que en el 2019 est\u00e0 dedicada a la recerca en c\u00e0ncer, una malaltia que a Espanya \u00e9s la primera causa de mort en homes i la segona en dones. Es calcula que un de cada dos homes i una de cada tres dones desenvoluparan un c\u00e0ncer al llarg de la seva vida.<\/p>\n

\u201cLa recerca en c\u00e0ncer salva vides\u201d, afirma el Dr. Gabriel Capell\u00e1, Director de l\u2019IDIBELL. \u201cEn els darrers anys hem avan\u00e7at molt, per\u00f2 \u00e9s necessari seguir investigant per reduir el temps de diagn\u00f2stic i aconseguir cronificar i curar la malaltia en el nombre m\u00e9s gran de persones possible\u201d.
Els fons recaptats en la campanya Salvem vides es destinaran a finan\u00e7ar projectes d\u2019investigaci\u00f3 de l\u2019Oncobell, el programa de recerca de l\u2019IDIBELL en ter\u00e0pies experimentals i mecanismes moleculars en c\u00e0ncer.
\u00a0<\/p>\n

La campanya es posa en marxa avui al web www.josalvovides.cat<\/a>, a l\u2019IDIBELL, en algunes institucions associades i en espais p\u00fablics, com el carrer o els mitjans de transport. Tamb\u00e9, a les xarxes socials. Els ciutadans, les empreses i els mitjans que ho desitgin podran col\u00b7laborar amb aportacions econ\u00f2miques, difusi\u00f3 o b\u00e9 mitjan\u00e7ant la participaci\u00f3 en els actes de la campanya.<\/p>\n

Un web de donacions i un spot d\u2019homenatge als donants<\/strong><\/u><\/p>\n

L\u2019anunci de la campanya Salvem Vides <\/a>ret homenatge als donants an\u00f2nims, per agrair la col\u00b7laboraci\u00f3 de la ciutadania per reunir recursos i ajudar a ampliar les alternatives terap\u00e8utiques i la qualitat de vida dels malalts a trav\u00e9s de la investigaci\u00f3, amb l\u2019objectiu \u00faltim de cronificar i curar el c\u00e0ncer. El missatge \u00e9s clar, explica el Dr. Ramon Salazar, coordinador del programa Oncobell: \u201cCom m\u00e9s inversi\u00f3, m\u00e9s de pressa avan\u00e7arem i m\u00e9s vides podrem salvar. Actualment ja som referent en el tractament de tumors minoritaris i cada dia avancem m\u00e9s cap a l\u2019aplicaci\u00f3 de ter\u00e0pies personalitzades, basades no nom\u00e9s en els aspectes cl\u00ednics habituals (bi\u00f2psies, par\u00e0metres cl\u00ednics, etc), sin\u00f3 incloent tamb\u00e9 la informaci\u00f3 gen\u00e8tica i sobre l\u2019estil de vida del pacient\u201d.<\/p>\n

Un bon exemple d\u2019aquest nou enfocament \u00e9s el projecte de la investigadora Ruth Rodr\u00edguez-Barrueco, recentment guardonada amb un dels Premis d\u2019Investigaci\u00f3 L\u2019Or\u00e9al-UNESCO \u201cFor women in science\u201d: \u201cVolem dissenyar m\u00e8todes de cribratge innovadors, mitjan\u00e7ant la nova tecnologia CRISPR, que ens permetin tractar tumors tenint en compte les c\u00e8l\u00b7lules que els envolten i activant el propi sistema immunitari del pacient per eliminar-los\u201d.<\/p>\n

Les persones i organitzacions que vulguin fer una aportaci\u00f3 econ\u00f2mica poden fer servir l\u2019aplicaci\u00f3 disponible al web de la campanya www.josalvovides.cat<\/a>, on tamb\u00e9 podran con\u00e8ixer millor la recerca que porten a terme els investigadors de l\u2019Oncobell i com contribuir a la difusi\u00f3 de la campanya Salvem vides, que sota les etiquetes #josalvovides i #yosalvovidas espera fer arribar els seus missatges i ampliar la recaptaci\u00f3 a trav\u00e9s de les xarxes socials.<\/p>\n

Els materials de la campanya Salvem vides tamb\u00e9 seran visibles a les instal\u00b7lacions de l\u2019IDIBELL, de l\u2019Hospital Universitari de Bellvitge, de l\u2019hospital oncol\u00f2gic Duran i Reynals, seu de l\u2019Institut Catal\u00e0 d\u2019Oncologia, del campus de Ci\u00e8ncies de la Salut de Bellvitge de la Universitat de Barcelona, i dels ajuntaments de l\u2019Hospital de Llobregat i a la majoria dels de la comarca del Baix Llobregat.\u00a0
\u00a0<\/p>\n","protected":false},"excerpt":{"rendered":"

L\u2019IDIBELL acaba d\u2019engegar la seva campanya anual de recaptaci\u00f3 de fons, que en el 2019 est\u00e0 dedicada a la recerca en c\u00e0ncer, una malaltia que a Espanya \u00e9s la primera causa de mort en homes i la segona en dones. Es calcula que un de cada dos homes i una de cada tres dones desenvoluparan […]<\/p>\n","protected":false},"author":6,"featured_media":10511,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"no-sidebar","site-content-layout":"page-builder","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"default","adv-header-id-meta":"","stick-header-meta":"default","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-gradient":""}},"footnotes":""},"categories":[332,491],"tags":[],"publishpress_future_action":{"enabled":false,"date":"2024-05-11 01:51:43","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category"},"_links":{"self":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7517"}],"collection":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/comments?post=7517"}],"version-history":[{"count":0,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/posts\/7517\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media\/10511"}],"wp:attachment":[{"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/media?parent=7517"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/categories?post=7517"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/idibell.cat\/wp-json\/wp\/v2\/tags?post=7517"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}